Obesity-Centric Medical Practice: A Shift in T2DM Management
Ildiko Lingvay presented a plenary talk at Obesity Week discussing weight-centric versus gluco-centric approaches to managing type 2 diabetes mellitus. She noted that while weight loss reduces T2DM risk, new therapies ma
At Obesity Week, Ildiko Lingvay from UT Southwestern Medical Center presented a plenary talk addressing the potential shift toward obesity-centric medical practice. The discussion focused on contrasting weight-centric versus gluco-centric approaches to managing patients with type 2 diabetes mellitus (T2DM). This topic is relevant in metabolic research contexts where understanding the causal relationship between body fat and disease progression remains critical for therapeutic development.
Lingvay highlighted that despite long-established associations between body fat and T2DM, current guidelines recommend weight loss as a primary intervention. Data supports that weight loss can markedly reduce T2DM risk, improve glucose control, and lead to remission. However, the author noted that clinicians have historically lacked effective tools to address obesity in patients with diabetes.
The presentation suggested that advances in Nutrient-Stimulated Hormone (NuSH) based therapies may change this landscape. These interventions result in weight loss comparable to surgical outcomes without surgery. Lingvay envisioned a future where anti-obesity medications become first-line treatments for T2DM and other conditions causally related to obesity, including sleep apnea, hypertension, and metabolic dysfunction-associated steatotic liver disease (MASLD).
Several limitations remain before widespread adoption of such therapies. Dedicated studies directly comparing obesity-centric approaches to usual care are needed across various indications. Access barriers, including cost and global supply constraints, currently limit availability. Additionally, clinicians must develop greater comfort with appropriate and safe use of these medications within patient-centric obesity care frameworks.
Despite these challenges, increasing evidence may transform treatment approaches for non-communicable chronic diseases where obesity remains a primary driver worldwide. The research underscores the need for continued investigation into obesity management strategies beyond traditional glucose-focused paradigms.